Our business solutions involves providing some initial feedback and advice on developing new products or improving existing technologies, improving processes, and improving designs.
Our business development is experiential and through the academic classroom setting. Experience in early-stage biotech company formation and product design and construction provides insights to assist in decision-making. Other expertise is in the field of Organizational Leadership and Entrepreneurial Leadership.
We consider global reach to consist of business initiatives that increase the visibility of the company with existing customers and future customers through the internet.
Gene therapy is a fast-growing area of health care. Paragon Bioservices, a Baltimore-based contract biologic drug manufacturer, is acquired for $1.2 billion by Catalent Inc. The company develops viral vectors for gene therapies, vaccine production, oncology immunotherapies, and therapeutic proteins.
Companies are evaluating their portfolios and strategically partnering with companies that can afford to expand their portfolios where others consider very niche areas. Divestitures and spinoffs will become more frequent for large global companies that become leaders of a specific specialty.
Digital therapeutics continue to play significant roles as tools for managing and treating chronic and acute medical disorders. Physicians, Nurses, and Health practitioners are including electronics for health management.
Laboratory considerations for sterility verification.
Prescription drug app development for understanding the effects of prescription drug medications.
Dental app development for improving consumer oral care and awareness.
Our experience spans from customer discovery, customer acquisition, market analysis, laboratory management, personnel management, organizational design, and organizational leadership theory. Grant writing, project management experience, networking experience, and business strategy are experiences that we can lend to assist in the early stages of your company.